Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients
Author:
Open Access
- 1 January 2015
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Nephrology
- Vol. 4 (3) , 388-95
Abstract
Antiretroviral therapy has markedly reduced acquired immune deficiency syndrome-related deaths and opportunistic infectious diseases. This has resulted in prolonged survival of individuals infected with the human immunodeficiency virus (HIV). However, this improvement in survival has been accompanied by an increase in the incidence of chronic kidney disease (CKD) and end-stage renal disease. CKD is now epidemic among HIV-infected populations in both Western and Eastern countries. Risk factors associated with CKD in HIV-infected populations include aging, hypertension, diabetes mellitus, co-infection with hepatitis C virus, a low CD4 cell count, and a high HIV viral load. Clinical experience has shown that HIV-infected individuals often have one or more concurrent risk factors for CKD. The cumulative effect of multiple risk factors on the development of CKD should be noted in this population. Glomerular disease directly related to HIV infection, so-called HIV-associated nephropathy, remains an important cause of CKD among a limited HIV population of African descent, but is less likely to be common among other urban HIV populations. The impact of exposure to nephrotoxic antiretroviral agents on the development of kidney disease is both an old and a new concern. In particular, the association of tenofovir with kidney tubular injury has been an area of great interest. The findings regarding tenofovir's adverse effect on long-term kidney function vary among studies. The early identification and treatment of CKD is recommended for reducing the burden of patients requiring dialysis in HIV-infected populations. Periodic monitoring of urinary concentrations of albumin, protein, and tubular injury markers such as low-molecular-weight proteins may be useful for the early diagnosis of patients at risk for incident CKD. This review focuses on recent epidemiology, clinical characteristics, and management of CKD in a contemporary HIV-infected population.Keywords
This publication has 76 references indexed in Scilit:
- A simple model for predicting incidence of chronic kidney disease in HIV-infected patientsClinical and Experimental Nephrology, 2011
- Microalbuminuria Is Associated With All-Cause and AIDS Mortality in Women With HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Association Between Kidney Function and Albuminuria With Cardiovascular Events in HIV-Infected PersonsCirculation, 2010
- Urinary NGAL Marks Cystic Disease in HIV-Associated NephropathyJournal of the American Society of Nephrology, 2009
- Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney diseaseAmerican Heart Journal, 2009
- Predictors of Renal Outcome in HIV‐Associated NephropathyClinical Infectious Diseases, 2008
- Chronic kidney disease perspectives in Japan and the importance of urinalysis screeningClinical and Experimental Nephrology, 2008
- Low Rates of Antiretroviral Therapy among HIV-Infected Patients with Chronic Kidney DiseaseClinical Infectious Diseases, 2007
- Cystatin C Level as a Marker of Kidney Function in Human Immunodeficiency Virus InfectionThe FRAM StudyArchives of internal medicine (1960), 2007
- Predicting initiation and progression of chronic kidney disease: Developing renal risk scoresKidney International, 2006